A detailed history of High Tower Advisors, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 14,910 shares of LXRX stock, worth $21,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,910
Holding current value
$21,321
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$0.42 - $0.95 $6,262 - $14,164
14,910 New
14,910 $14,000
Q2 2021

Aug 06, 2021

SELL
$4.12 - $5.87 $44,920 - $64,000
-10,903 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$3.45 - $9.09 $37,615 - $99,108
10,903 New
10,903 $64,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $270M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.